Drug category:
A lipid-lowering agent

Composition:
Mavest 10mg tablet contains Simvastatin 10mg as active ingredient.
Mavest 20mg tablet contains Simvastatin 20mg as active ingredient.
 

Indications:
- Coronary Heart Disease (CHD)
- In patients with coronary heart disease and hypercholesterolemia, simvastatin is indicated to:
- Reduce the risk of total mortality by reducing coronary death.
- Reduce the risk of non-fatal myocardial infarction.
- Reduce the risk for undergoing myocardial revascularization procedures.
- Reduce the risk of stroke or transient ischemic attack.
- Hyperlipidemia
- Simvastatin is indicated as an adjunct to diet to reduce elevated total-C, LDL-C, Apo B, and TG levels, and to increase HDL-C in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia.
- Simvastatin is also indicated to reduce total-C and LDL-C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatments.
 

Dosage and Administration:
The recommended usual starting dose is 20 mg once a day in the evening. Patients who require a moderate reduction of LDL-C may start at 10 mg.
 

Presentation:
Mavest 10mg tablets in blister packs of 10's.
Mavest 20mg tablets in blister packs of 10's